Skip to content

Sustainable Anaesthesia Practices in EUROPE - a Prospective International Cohort Study

Sustainable Anaesthesia Practices in EUROPE

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07252973
Acronym
SUSTAIN-EUROPE
Enrollment
2000
Registered
2025-11-28
Start date
2026-03-01
Completion date
2027-03-01
Last updated
2025-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia Conduction, Carbon Footprint in Anesthetic, Paediatric and Adult Patients

Brief summary

In response to the climate crises, Societies of Anaesthesiology around the globe call for action to reduce the carbon footprint of daily clinical work. They recommend the use of regional and total intravenous anaesthesia, and for inhalational anaesthesia cases, the use of sevoflurane with low fresh gas flow (FGF \< 0.5 lpm) settings. Surprisingly, the type of anaesthesia and ventilation settings commonly used remain largely unknown. This pragmatic observational cross-sectional assessment at all anaesthesia workstations in participating European hospitals in daily routine aims to evaluate anaesthesia practices in the paediatric and adult patient population.

Interventions

OTHERAnaesthesia technique

Observation of type of anaesthesia used in Europe

Sponsors

European Society of Anaesthesiology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients receiving any form of anaesthesia care-whether general or regional anaesthesia, monitored sedation, or monitoring only-from an anaesthetist at an anaesthesia workstation in participating European hospitals during the selected data-collection recruitment period

Exclusion criteria

* Patients (or legal guardians) who decline consent and patients for whom valid informed consent cannot be obtained due to language barriers or other factors preventing adequate information and understanding.

Design outcomes

Primary

MeasureTime frameDescription
Type of anaesthesia (inhalational and intravenous general anaesthesia, regional anaesthesia, sedation, combinations, monitoring only)5-60 min after the skin incisionThe type of anaesthesia (inhalational and intravenous general anaesthesia, regional anaesthesia, sedation, combinations, or monitoring only) will be recorded by a trained team member collecting data perioperatively 5-60 minutes after skin incision or start of procedure, respectively. In the event that the anaesthetic approach changes intraoperatively, only the technique recorded at that time point will be used for analysis. Any local anaesthetic infiltration performed by the anaesthetist will be classified as regional anaesthesia, whereas if the surgeon alone administers local anaesthetic, this will not be classified by regional anaesthesia.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026